214 related articles for article (PubMed ID: 36982788)
41. Differential transcriptional regulation of hypoxia-inducible factor-1α by arsenite under normoxia and hypoxia: involvement of Nrf2.
Al Taleb Z; Petry A; Chi TF; Mennerich D; Görlach A; Dimova EY; Kietzmann T
J Mol Med (Berl); 2016 Oct; 94(10):1153-1166. PubMed ID: 27286880
[TBL] [Abstract][Full Text] [Related]
42. Hypoxia-Inducible Factor-1α (HIF-1α) Promotes Hypoxia-Induced Invasion and Metastasis in Ovarian Cancer by Targeting Matrix Metallopeptidase 13 (MMP13).
Zhang H; Yang Q; Lian X; Jiang P; Cui J
Med Sci Monit; 2019 Sep; 25():7202-7208. PubMed ID: 31587013
[TBL] [Abstract][Full Text] [Related]
43. Diindolylmethane suppresses ovarian cancer growth and potentiates the effect of cisplatin in tumor mouse model by targeting signal transducer and activator of transcription 3 (STAT3).
Kandala PK; Srivastava SK
BMC Med; 2012 Jan; 10():9. PubMed ID: 22280969
[TBL] [Abstract][Full Text] [Related]
44. MFTZ-1 reduces constitutive and inducible HIF-1α accumulation and VEGF secretion independent of its topoisomerase II inhibition.
Dai M; Miao ZH; Ren X; Tong LJ; Yang N; Li T; Lin LP; Shen YM; Ding J
J Cell Mol Med; 2010 Sep; 14(9):2281-91. PubMed ID: 19538463
[TBL] [Abstract][Full Text] [Related]
45. Hypoxia-induced vascular endothelial growth factor secretion by retinal pigment epithelial cells is inhibited by melatonin via decreased accumulation of hypoxia-inducible factors-1α protein.
Lai YH; Hu DN; Rosen R; Sassoon J; Chuang LY; Wu KY; Wu WC
Clin Exp Ophthalmol; 2017 Mar; 45(2):182-191. PubMed ID: 27409056
[TBL] [Abstract][Full Text] [Related]
46. An Akt/hypoxia-inducible factor-1alpha/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells.
Lau CK; Yang ZF; Ho DW; Ng MN; Yeoh GC; Poon RT; Fan ST
Clin Cancer Res; 2009 May; 15(10):3462-71. PubMed ID: 19447872
[TBL] [Abstract][Full Text] [Related]
47. Hypoxia inducible factor-1α/vascular endothelial growth factor signaling activation correlates with response to radiotherapy and its inhibition reduces hypoxia-induced angiogenesis in lung cancer.
Zhu H; Zhang S
J Cell Biochem; 2018 Sep; 119(9):7707-7718. PubMed ID: 29904944
[TBL] [Abstract][Full Text] [Related]
48. The proliferation, apoptosis, invasion of endothelial-like epithelial ovarian cancer cells induced by hypoxia.
Zhu P; Ning Y; Yao L; Chen M; Xu C
J Exp Clin Cancer Res; 2010 Sep; 29(1):124. PubMed ID: 20831794
[TBL] [Abstract][Full Text] [Related]
49. Melatonin restricts the viability and angiogenesis of vascular endothelial cells by suppressing HIF-1α/ROS/VEGF.
Cheng J; Yang HL; Gu CJ; Liu YK; Shao J; Zhu R; He YY; Zhu XY; Li MQ
Int J Mol Med; 2019 Feb; 43(2):945-955. PubMed ID: 30569127
[TBL] [Abstract][Full Text] [Related]
50. Ursolic acid sensitized colon cancer cells to chemotherapy under hypoxia by inhibiting MDR1 through HIF-1α.
Shan JZ; Xuan YY; Zhang Q; Huang JJ
J Zhejiang Univ Sci B; 2016 Sep; 17(9):672-82. PubMed ID: 27604859
[TBL] [Abstract][Full Text] [Related]
51. BRCA1 plays a role in the hypoxic response by regulating HIF-1alpha stability and by modulating vascular endothelial growth factor expression.
Kang HJ; Kim HJ; Rih JK; Mattson TL; Kim KW; Cho CH; Isaacs JS; Bae I
J Biol Chem; 2006 May; 281(19):13047-13056. PubMed ID: 16543242
[TBL] [Abstract][Full Text] [Related]
52. [Effect of hypoxia on the chemotherapeutic sensitivity of human ovarian cancer cells to paclitaxel and its mechanism].
Huang L; Zhang QH; Ao QL; Xing H; Lu YP; Ma D
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):96-100. PubMed ID: 17645840
[TBL] [Abstract][Full Text] [Related]
53. A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells.
Ahmed EM; Bandopadhyay G; Coyle B; Grabowska A
Cell Oncol (Dordr); 2018 Jun; 41(3):319-328. PubMed ID: 29492900
[TBL] [Abstract][Full Text] [Related]
54. Rhapontigenin inhibited hypoxia inducible factor 1 alpha accumulation and angiogenesis in hypoxic PC-3 prostate cancer cells.
Jung DB; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Kim YC; Ahn KS; Chen CY; Kim SH
Biol Pharm Bull; 2011; 34(6):850-5. PubMed ID: 21628883
[TBL] [Abstract][Full Text] [Related]
55. Interaction between p53 and Ras signaling controls cisplatin resistance via HDAC4- and HIF-1α-mediated regulation of apoptosis and autophagy.
Zhang X; Qi Z; Yin H; Yang G
Theranostics; 2019; 9(4):1096-1114. PubMed ID: 30867818
[TBL] [Abstract][Full Text] [Related]
56. HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs).
De Francesco EM; Lappano R; Santolla MF; Marsico S; Caruso A; Maggiolini M
Breast Cancer Res; 2013; 15(4):R64. PubMed ID: 23947803
[TBL] [Abstract][Full Text] [Related]
57. Modulation of cisplatin sensitivity in human ovarian carcinoma A2780 and SKOV3 cell lines by sulforaphane.
Hunakova L; Gronesova P; Horvathova E; Chalupa I; Cholujova D; Duraj J; Sedlak J
Toxicol Lett; 2014 Nov; 230(3):479-86. PubMed ID: 25159039
[TBL] [Abstract][Full Text] [Related]
58. Theasaponin E
Li B; Tong T; Ren N; Rankin GO; Rojanasakul Y; Tu Y; Chen YC
Molecules; 2021 Mar; 26(6):. PubMed ID: 33802884
[TBL] [Abstract][Full Text] [Related]
59. Mechanism of vascular endothelial growth factor expression mediated by cisplatin in human ovarian cancer cells.
Zhong XS; Liu LZ; Skinner HD; Cao Z; Ding M; Jiang BH
Biochem Biophys Res Commun; 2007 Jun; 358(1):92-8. PubMed ID: 17470361
[TBL] [Abstract][Full Text] [Related]
60. Overcoming evasive resistance from vascular endothelial growth factor a inhibition in sarcomas by genetic or pharmacologic targeting of hypoxia-inducible factor 1α.
Kim YJ; Lee HJ; Kim TM; Eisinger-Mathason TS; Zhang AY; Schmidt B; Karl DL; Nakazawa MS; Park PJ; Simon MC; Yoon SS
Int J Cancer; 2013 Jan; 132(1):29-41. PubMed ID: 22684860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
